Lantus is being replaced

Lantus is a long-acting basal insulin which has been around since 2000. That’s about to change, but don’t panic. Essentially it’s just a name change. History Lantus is a U100 form of insulin glargine, made by Sanofi. Its patent protection eventually ran out, so new versions started appearing from other companies. Lilly (who also make Humalog) …

Lantus is being replaced Read More »

New Year: new Safety Nets

It’s not cheap having chronic health conditions and constantly needing medication. There are some government concessions available beyond the standard PBS subsidy, but we need to take charge and make sure we’re not missing out on them! PBS Safety Net I had to go to a pharmacy today, and being the start of a new …

New Year: new Safety Nets Read More »

Another insulin – October 2019

In the October update to the Australian PBS (Pharmaceutical Benefits Scheme), another insulin arrived today. Well, sort of. The addition is Semglee, which is a “biosimilar equivalent” to Lantus. Like Lantus it’s insulin glargine. Lantus is one of the commonly-used long-acting (or “basal”) insulin used for daily injections. It’s been around for years (I used …

Another insulin – October 2019 Read More »